Efficacy of tacrolimus against Churg-Strauss syndrome in a patient with myasthenia gravis.
Niiyama
Shiro
S
Amoh
Yasuyuki
Y
Suzuki
Kosuke
K
Wada
Tatsuhiko
T
Katsuoka
Kensei
K
D000368:Aged; D001249:Asthma / Q000150:complications* / Q000276:immunology; D001808:Blood Vessels / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D015267:Churg-Strauss Syndrome / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D015897:Comorbidity; D004802:Eosinophilia / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009157:Myasthenia Gravis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D010024:Osteoporosis / Q000139:chemically induced; D011239:Prednisolone / Q000009:adverse effects; D012867:Skin / Q000098:blood supply / Q000187:drug effects / Q000276:immunology; D016559:Tacrolimus / Q000627:therapeutic use*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D011239:Prednisolone; D016559:Tacrolimus